Clinical Trial Update: Brazilian Green Propolis Extract (EPP-AF) as an Adjunct Treatment for Hospitalized COVID-19 Patients (BeeCovid2) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trials evaluating Brazilian Green Propolis Extract (EPP-AF) as an adjunct treatment for hospitalized COVID-19 patients have completed Phase 2 and Phase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammation

Drugs mentioned

• Brazilian Green Propolis Extract (EPP-AF)

Snippet

Sponsor: D'Or Institute for Research and Education | Conditions: Covid19, Inflammation | Phase 2, Phase 3 | Status: COMPLETED